204 related articles for article (PubMed ID: 37201112)
1. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
2. PD-1
Liu X; Li M; Wang X; Dang Z; Jiang Y; Wang X; Kong Y; Yang Z
Cancer Immunol Immunother; 2019 Dec; 68(12):2041-2054. PubMed ID: 31720814
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome as a biomarker for predicting early recurrence of HBV-related hepatocellular carcinoma.
Zheng C; Lu F; Chen B; Yang J; Yu H; Wang D; Xie H; Chen K; Xie Y; Li J; Bo Z; Wang Y; Chen G; Deng T
Cancer Sci; 2023 Dec; 114(12):4717-4731. PubMed ID: 37778742
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Lactic Acid Bacteria Anti-Hepatitis B Virus (HBV) Effect and Modulation of the Intestinal Microbiota in Fecal Cultures from HBV-Associated Hepatocellular Carcinoma Patients.
Yang J; Gao H; Zhang T; Fan Y; Wu Y; Zhao X; Li Y; Wu L; Zhao H; Yang L; Zhong H; Li L; Xie X; Wu Q
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474727
[TBL] [Abstract][Full Text] [Related]
5. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.
Huang JH; Wang J; Chai XQ; Li ZC; Jiang YH; Li J; Liu X; Fan J; Cai JB; Liu F
Microbiol Spectr; 2022 Oct; 10(5):e0098322. PubMed ID: 36173308
[TBL] [Abstract][Full Text] [Related]
6. Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma.
Bai Q; Li R; He X; Hong X; Yan Y; Zhao Z; Lin H; Tacke F; Engelmann C; Hu T
Front Immunol; 2023; 14():1320414. PubMed ID: 38116005
[TBL] [Abstract][Full Text] [Related]
7. Relationship between gut microbiota dysbiosis and immune indicator in children with sepsis.
Lin X; Abdalla M; Yang J; Liu L; Fu Y; Zhang Y; Yang S; Yu H; Ge Y; Zhang S; Kang G; Dang W; Jiang Q; Wang Y; Gai Z
BMC Pediatr; 2023 Oct; 23(1):516. PubMed ID: 37845615
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4 + T cell reduction and immune activation.
Zhou J; Yang Y; Xie Z; Lu D; Huang J; Lan L; Guo B; Yang X; Wang Q; Li Z; Zhang Y; Yang X; Ai S; Liu N; Cui P; Liang H; Ye L; Huang J
AIDS; 2024 Apr; 38(5):633-644. PubMed ID: 38061029
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
[TBL] [Abstract][Full Text] [Related]
10. Ethanol-Producing
Magdy Wasfy R; Mbaye B; Borentain P; Tidjani Alou M; Murillo Ruiz ML; Caputo A; Andrieu C; Armstrong N; Million M; Gerolami R
Microorganisms; 2023 Sep; 11(10):. PubMed ID: 37894093
[TBL] [Abstract][Full Text] [Related]
11. Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives.
Feng J; Wu Y; Dai P; Wang D; Liu L; Chai B
J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37777841
[TBL] [Abstract][Full Text] [Related]
12. Altered intestinal microbiota enhances adenoid hypertrophy by disrupting the immune balance.
Liu W; Jiang H; Liu X; Zheng Y; Liu Y; Pan F; Yu F; Li Z; Gu M; Du Q; Li X; Zhang H; Han D
Front Immunol; 2023; 14():1277351. PubMed ID: 38090578
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis of Gut Microbiota Contributes to Uremic Cardiomyopathy via Induction of IFNγ-Producing CD4
Han B; Zhang X; Wang L; Yuan W
Microbiol Spectr; 2023 Feb; 11(1):e0310122. PubMed ID: 36788674
[TBL] [Abstract][Full Text] [Related]
14. Altered Gut Microbial Profile Accompanied by Abnormal Fatty Acid Metabolism Activity Exacerbates Endometrial Cancer Progression.
Zhao SS; Chen L; Yang J; Wu ZH; Wang XY; Zhang Q; Liu WJ; Liu HX
Microbiol Spectr; 2022 Dec; 10(6):e0261222. PubMed ID: 36227107
[TBL] [Abstract][Full Text] [Related]
15. Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade.
SahBandar IN; Chew GM; Corley MJ; Pang APS; Tsai N; Hanks N; Khadka VS; Klatt NR; Hensley-McBain T; Somsouk M; Vujkovic-Cvijin I; Chow DC; Shikuma CM; Ndhlovu LC
AIDS; 2020 Aug; 34(10):1451-1460. PubMed ID: 32675558
[TBL] [Abstract][Full Text] [Related]
16. Alteration in gut microbiota is associated with immune imbalance in Graves' disease.
Liu Y; Tang S; Feng Y; Xue B; Cheng C; Su Y; Wei W; Zhang L; Huang Z; Shi X; Fang Y; Yang J; Zhang Y; Deng X; Wang L; Ren H; Wang C; Yuan H
Front Cell Infect Microbiol; 2024; 14():1349397. PubMed ID: 38533382
[TBL] [Abstract][Full Text] [Related]
17. Supplementing Ryegrass Ameliorates Commercial Diet-Induced Gut Microbial Dysbiosis-Associated Spleen Dysfunctions by Gut-Microbiota-Spleen Axis.
Ali Q; Ma S; Liu B; Niu J; Liu M; Mustafa A; Li D; Wang Z; Sun H; Cui Y; Shi Y
Nutrients; 2024 Mar; 16(5):. PubMed ID: 38474875
[TBL] [Abstract][Full Text] [Related]
18. [Comparative analysis of intestinal microbiota distribution characteristics based on metagenomics in patients with hepatitis B cirrhosis with or without ascites].
Luan YT; Liu CH; Jiang SL; Gu HT; Lyu J; Xing F; Zhao CQ; Yuan JL; Liu P; Mu YP
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):974-985. PubMed ID: 37872094
[No Abstract] [Full Text] [Related]
19. Human gut microbiota from hepatitis B virus-infected individuals is associated with reduced triglyceride level in mice: faecal transplantation study.
Kim HN; Cheong HS; Kim B; Sohn W; Cho YK; Kwon MJ; Kim J; Song Y; Joo EJ
Microbes Infect; 2024; 26(3):105281. PubMed ID: 38128750
[TBL] [Abstract][Full Text] [Related]
20. Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma.
Cho EJ; Kim B; Yu SJ; Hong SK; Choi Y; Yi NJ; Lee KW; Suh KS; Yoon JH; Park T
Br J Cancer; 2024 Apr; 130(6):970-975. PubMed ID: 38278977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
